These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12150695)

  • 61. Polycystic Ovary Syndrome: A Contemporary Clinical Approach.
    Bjekić-Macut J; Vukašin T; Velija-Ašimi Z; Bureković A; Zdravković M; Andrić Z; Branković M; Crevar-Marinović S; Madić T; Stanojlović O; Milutinović DV; Livadas S; Mastorakos G
    Curr Pharm Des; 2021; 27(36):3812-3820. PubMed ID: 33463457
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
    Nawaz FH; Rizvi J
    Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Metformin therapy in polycystic ovary syndrome].
    Jakimiuk AJ
    Ginekol Pol; 2008 Jan; 79(1):8-11. PubMed ID: 18510043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
    Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
    Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes.
    Sills ES; Perloe M; Palermo GD
    Eur J Obstet Gynecol Reprod Biol; 2000 Aug; 91(2):135-41. PubMed ID: 10869785
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effects of metformin therapy on markers of coagulation disorders in hyperinsulinemic women with polycystic ovary syndrome].
    Serdyńska-Szuster M; Banaszewska B; Spaczyński R; Pawelczyk L
    Ginekol Pol; 2011 Apr; 82(4):259-64. PubMed ID: 21735693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.
    Khattab S; Mohsen IA; Aboul Foutouh I; Ashmawi HS; Mohsen MN; van Wely M; van der Veen F; Youssef MA
    Gynecol Endocrinol; 2011 Oct; 27(10):789-93. PubMed ID: 21247239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of metformin for ovulation induction in women who have polycystic ovary syndrome with or without evidence of insulin resistance.
    Liu KE; Tataryn IV; Sagle M
    J Obstet Gynaecol Can; 2006 Jul; 28(7):595-599. PubMed ID: 16916482
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2009; 15(26):3074-7. PubMed ID: 19754381
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thiazolinedione treatment in PCOS--an update.
    Glintborg D; Andersen M
    Gynecol Endocrinol; 2010 Nov; 26(11):791-803. PubMed ID: 20528570
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin-sensitizing agents in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome.
    Kazerooni T; Ghaffarpasand F; Kazerooni Y; Kazerooni M; Setoodeh S
    Int J Gynaecol Obstet; 2009 Oct; 107(1):50-3. PubMed ID: 19552904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M; Kamenov Z; Kolarov G; Zakharieva S; Khristov V; Atanasova I; Shigarminova R; Milcheva B; Genchev G
    Akush Ginekol (Sofiia); 2006; 45(7):16-28. PubMed ID: 17489164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin sensitizers in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Front Horm Res; 2013; 40():83-102. PubMed ID: 24002407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.